Unlock instant, AI-driven research and patent intelligence for your innovation.

Use of lychee seed active ingredients in preparation of medicament for improving insulin resistance

An insulin resistance and drug technology, applied in the field of medicine, can solve the problems of improving peripheral and central insulin resistance effectively.

Inactive Publication Date: 2018-10-23
SOUTHWEST MEDICAL UNIVERISTY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in the prior art, there is no public report on whether litchi core extract can improve peripheral and central insulin resistance when it is used as a unique medicinal material, and there is no information about which specific substances in litchi core extract can effectively exert Reports on improving IR and alleviating AD efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of lychee seed active ingredients in preparation of medicament for improving insulin resistance
  • Use of lychee seed active ingredients in preparation of medicament for improving insulin resistance
  • Use of lychee seed active ingredients in preparation of medicament for improving insulin resistance

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] PAS glycogen staining to observe the improvement effects of procyanidin A1 and procyanidin A2 on peripheral insulin resistance and central insulin resistance, respectively

[0044] S1: set Insulin resistance model group (simplified called, model group), including: HepG2 treated with 1 μmol·L -1 Peripheral insulin resistance model group formed after 48h of dexamethasone; and, treated with 2 μmol L -1 The central insulin resistance model group formed after dexamethasone treatment for 24 hours. Its specific cultivation operation steps are:

[0045] Establishment of peripheral insulin resistance model: take HepG2 cells in the logarithmic growth phase, trypsinize and adjust the cell density to 1×10 5 pcs mL -1 , inoculated in a 96-well plate, 100uL per well, placed in a 37°C, 5% CO2 incubator for 24h, after the cells adhered to the wall, discard the medium, and replace it with a serum-free medium for starvation induction for 12h, discard the medium, and use 1μmol· L -...

Embodiment 2

[0059] Effects of procyanidin A1 and / or procyanidin A2 on IRS-1, PI3K, Akt, GSK3β, Tau mRNA in HT22 cells

[0060] Real-time fluorescent quantitative PCR (Quantitative Real Time PCR) was used to verify the effects of procyanidin A1 and procyanidin A2 on IRS-1, PI3K, Akt, GSK3β, and Tau mRNA in HT22 cells. The specific operation steps were as follows:

[0061] 1. Cell treatment

[0062] Set up blank control group, central insulin resistance model group, pioglitazone group, litchi kernel mixed extract group, procyanidin A1 group and procyanidin A2 group. in,

[0063] Take HT22 cells in the logarithmic growth phase, trypsinize and adjust the cell density to 1×10 5 pcs mL -1 , seeded in a 6-well plate, 2 mL per well, at 37 ° C, 5% CO 2 In the incubator for 24 hours, after the cells adhered to the wall, replace the serum-free medium for starvation induction for 12 hours, discard the medium, and use 1 μmol L -1 After being treated with dexamethasone for 48 hours, the central insu...

Embodiment 3

[0096] Effects of procyanidin A1 and / or procyanidin A2 on the phosphorylation levels of IRS-1, PI3K, Akt, GSK3β and Tau total protein in HT22 cells

[0097] Western blot was used to verify the effects of procyanidin A1 and procyanidin A2, the active substances of litchi nucleus, on the phosphorylation levels of IRS-1, PI3K, Akt, GSK3β, and Tau proteins in HT22 cells. The specific experimental steps are as follows:

[0098] 1. Cell treatment is the same as in Example 2

[0099] 2. Protein extraction:

[0100] ①Discard the culture medium, wash with pre-cooled PBS for 3 times, each time for 5 minutes, prepare the lysate according to the ratio of RIRP strong lysate: protease inhibitor: phosphatase inhibitor = 8:1:1, add 200 μL of lysate to each well solution, lysed on ice for 30 min;

[0101] ②Scrape off the cells with a cell scraper, transfer them completely to a 1.5mL EP tube with a pipette tip, and lyse them by ultrasonication for 5sec;

[0102] ③ After centrifugation at 4°C...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicine and specifically discloses a use of lychee seed active ingredients procyanidin A1 and / or procyanidin A2 in preparation of a medicament for improving insulin resistance. The procyanidin A1 and procyanidin A2 activate a PI3K / Akt signal path, reduce GSK3 beta activity, inhibit the abnormal phosphorylation of a Tau protein, significantly improve peripheral insulin resistance and central insulin resistance, and can be used for preparation of a medicament for improving insulin resistance and especially for preparation of a medicament for treating Alzheimer's disease and / or a medicament for treating diabetes.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the use of procyanidin A1 and procyanidin A2, which are active components of litchi kernels, in the preparation of medicines for improving insulin resistance. Background technique [0002] Peripheral and central insulin resistance (Insulin resistance, referred to as IR) is the decreased sensitivity of the body's tissue cells to insulin, and its main features are hyperinsulinemia and damage to the insulin signaling pathway, which is the main cause of type 2 diabetes (T2DM). The pathogenesis can cause various diseases such as diabetes and Alzheimer's disease (AD) (refer to non-patent documents 1 and 2). Among them, IR, diabetes and AD are closely related: epidemiological statistics show that compared with normal people, diabetic patients have a 65% higher risk of suffering from AD; in the pathogenesis of the two, brain-specific central insulin molecules and signaling The transd...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/353A61P5/50A61P3/10A61P25/28
CPCA61K31/353A61P3/10A61P5/50A61P25/28
Inventor 秦大莲吴建明王秀玲唐勇吴安国黄飞鸿
Owner SOUTHWEST MEDICAL UNIVERISTY